Home Healthcare Global Monoclonal Antibodies Mabs Market
global monoclonal antibodies mabs market

Monoclonal Antibodies (mAbs) Market [By Product Type (Fully Human, Murine, Chimeric); By Production System (Mammalian Cell Culture, Microbial Fermentation); By Indication (Cancer, Inflammation, Cardiovascular diseases, Transplant Rejection, Respiratory and Infectious diseases); By Technology Platforms (Transgenic-Mouse, Antibody Drug Conjugate, Phage-Display); By Target Mechanism of Action (CGRP, HER2, CTLA4, TNF alpha, EGFR, VEGF, Anti CD, Anti IL, IgGs, PD-1/PD-L1), By Care Delivery Setting; By Drug Types & By Region]: Market Size & Forecast, 2017 - 2026

  • Published Date: Feb 2018
  • Pages: 130
  • Format: PDF
  • Report ID: PM1104
  • Base Year: 2017
  • Historical Data: 2015-2017

Table of Contents

  1. Overview and Scope
    1. Research goal & scope
    2. Research assumptions
    3. Research methodology
      1. Primary data sources
      2. Secondary data sources
    4. Key take-away
    5. Stakeholders
  2. Executive Summary
    1. Market definition
    2. Market segmentation
  3. Monoclonal Antibodies Market Insights
    1. Monoclonal Antibodies – Industry snapshot
    2. Monoclonal Antibodies - Ecosystem analysis
    3. Monoclonal Antibodies Market Dynamics
      1. Monoclonal Antibodies – Market Forces
        1. Monoclonal Antibodies Market Driver Analysis
        2. Monoclonal Antibodies Market Restraint/Challenges analysis
        3. Monoclonal Antibodies Market Opportunity Analysis
      2. Industry analysis - Porter's five forces
        1. Bargaining power of supplier
        2. Bargaining power of buyer
        3. Threat of substitute
        4. Threat of new entrant
        5. Degree of competition
      3. Monoclonal Antibodies Market PEST Analysis, 2017
      4. Monoclonal Antibodies Market Value Chain Analysis
      5. Monoclonal Antibodies Industry Trends
      6. Competitive Ranking Analysis
  4. Monoclonal Antibodies Testing Market Size and Forecast, 2017-2026 by Product Type
    1. Key Findings
    2. Fully Human
    3. Murine
    4. Chimeric
    5. Humanized
  5. Monoclonal Antibodies Testing Market Size and Forecast, 2017-2026 by Production System
    1. Key Findings
    2. Mammalian Cell Culture
    3. Microbial Fermentation
  6. Monoclonal Antibodies Testing Market Size and Forecast, 2017-2026 by Indication
    1. Key Findings
    2. Cancer
    3. Inflammation
    4. Cardiovascular diseases
    5. Transplant Rejection
    6. Respiratory
    7. Infectious diseases
  7. Monoclonal Antibodies Testing Market Size and Forecast, 2017-2026 by Technology Platforms
    1. Key Findings
    2. Transgenic-Mouse
    3. Antibody Drug Conjugate
    4. Phage-Display
  8. Monoclonal Antibodies Testing Market Size and Forecast, 2017-2026 by Target Mechanism of Action
    1. Key Findings
    2. CGRP
    3. HER2
    4. CTLA4
    5. TNF alpha
    6. EGFR
    7. VEGF
    8. Anti CD
    9. Anti-IL
    10. IgGs, PD-1/PD-L1
  9. Monoclonal Antibodies Testing Market Size and Forecast, 2017-2026 by Care Delivery Setting
    1. Key Findings
    2. Primary
    3. Specialty Care
  10. Monoclonal Antibodies Testing Market Size and Forecast, 2017-2026 by Route of Administration
    1. Key Findings
    2. Subcutaneous
    3. Intravenous
  11. Monoclonal Antibodies Testing Market Size and Forecast, 2017-2026 by Drug Types
    1. Key Findings
    2. Branded Biologics
    3. Biosimilars
  12. Monoclonal Antibodies Testing Market Size and Forecast, 2017-2026 by Region
    1. Key Findings
    2. North America
      1. U.S.
      2. Canada
    3. Europe
      1. UK
      2. Germany
      3. Rest of Europe
    4. Asia-Pacific
      1. China
      2. Japan
      3. India
      4. Rest of Asia-Pacific
    5. Latin America
      1. Brazil
      2. Mexico
    6. Middle East & Africa
      1. South Africa
      2. Rest of Middle East & Africa
  13. Company Profiles
    1. Pfizer, Inc.,
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
    2. GlaxoSmithKline PLC
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
    3. Novartis AG
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
    4. Merck & Co., Inc.
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
    5. Eli Lily & Co.
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
    6. AstraZeneca
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
    7. Amgen, Inc.
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
    8. Abbott Laboratories
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
    9. Thermo Fisher Scientific, Inc.
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
    10. Bistro-Myers Squibb.
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
    11. Mylan N.V.
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
    12. Daiichi Sankyo Company, Ltd.
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
    13. Bayer AG
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
    14. Hoffmann-La Roche Ltd.
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
    15. Novo Nordisk A/S
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
Polaris Market Research
Monoclonal Antibodies (mAbs) Market Size, Share | Industry Forecast 2026